PTPN13 and hepatocellular carcinoma: To verify this hypothesis, we used Sequenom MassARRAY quantitative methylation analysis to determine that the PTPN13 promoter methylation level was higher in 4 HBV + HCC samples than in 3 HBV-HCC samples (Fig. 2D).